Goodrx Holdings earnings were $30.4M for the trailing 12 months ending Dec 31, 2025, with 125% growth year over year. The latest GDRX earnings report on Dec 31, 2025 announced Q4 2025 earnings of $5.4M, up 384.8% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GDRX reported annual earnings of $30.4M, with 85.7% growth.
GDRX past earnings growth
How has GDRX's earnings growth performed historically?
What were Goodrx Holdings's earnings last quarter?
On GDRX's earnings call on Invalid Date, Goodrx Holdings (NASDAQ: GDRX) reported Q4 2025 earnings per share (EPS) of $0.02, up 100% year over year. Total GDRX earnings for the quarter were $5.43 million. In the same quarter last year, Goodrx Holdings's earnings per share (EPS) was $0.01.
As of the last Goodrx Holdings earnings report, Goodrx Holdings is currently profitable. Goodrx Holdings's net profit (also called net income) for the twelve months ending Dec 31, 2025 was $30.44 million, a 85.72% increase year over year.
What was GDRX's earnings growth in the past year?
As of Goodrx Holdings's earnings date in Invalid Date, Goodrx Holdings's earnings has grown 125% year over year. This is 92.67 percentage points higher than the US Health Information Services industry earnings growth rate of 32.33%. GDRX earnings in the past year totalled $30.44 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.